Plasma MMP-9/TIMP-1 ratio serves as a novel potential biomarker in Alzheimer’s disease
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Plasma MMP-9/TIMP-1 ratio serves as a novel potential biomarker in Alzheimer’s disease
Authors
Keywords
-
Journal
NEUROREPORT
Volume 34, Issue 15, Pages 767-772
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2023-09-12
DOI
10.1097/wnr.0000000000001952
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Non-Coding RNAs as Novel Regulators of Neuroinflammation in Alzheimer’s Disease
- (2022) Yuqing Liu et al. Frontiers in Immunology
- SIRT1, MMP-9 and TIMP-1 levels in children with specific learning disorder
- (2022) Cansu Mercan Isik et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Highly specific and ultrasensitive plasma test detects Abeta(1–42) and Abeta(1–40) in Alzheimer’s disease
- (2021) Elisabeth H. Thijssen et al. Scientific Reports
- Biomarkers for neurodegenerative diseases
- (2021) Oskar Hansson NATURE MEDICINE
- Blood-based biomarkers for Alzheimer's disease: towards clinical implementation
- (2021) Charlotte E Teunissen et al. LANCET NEUROLOGY
- Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study
- (2020) Longfei Jia et al. Lancet Public Health
- Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2019) Maigeng Zhou et al. LANCET
- Influence of Matrix Metallopeptidase 9 on Beta-Amyloid Elimination Across the Blood-Brain Barrier
- (2019) Ben Shackleton et al. MOLECULAR NEUROBIOLOGY
- Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer’s disease
- (2019) Christopher D. Whelan et al. Acta Neuropathologica Communications
- Mortality of Alzheimer’s Disease Patients: A 10-Year Follow-up Pilot Study in Shanghai
- (2019) Yue-Qi Zhang et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- The cost of Alzheimer's disease in China and re-estimation of costs worldwide
- (2018) Jianping Jia et al. Alzheimers & Dementia
- Cerebrospinal Fluid Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Combination with Subcortical and Cortical Biomarkers in Vascular Dementia and Alzheimer's Disease
- (2018) Maria Bjerke et al. JOURNAL OF ALZHEIMERS DISEASE
- Investigation of Matrix Metalloproteinases, MMP-2 and MMP-9, in Plasma Reveals a Decrease of MMP-2 in Alzheimer's Disease
- (2018) Nastasia K.-H. Lim et al. JOURNAL OF ALZHEIMERS DISEASE
- Analysis of Matrix Metallo-Proteases and the Plasminogen System in Mild Cognitive Impairment and Alzheimer's Disease Cerebrospinal Fluid
- (2018) Cecilia E. Hanzel et al. JOURNAL OF ALZHEIMERS DISEASE
- Concentrations of Matrix Metalloproteinases and their Tissue Inhibitors in the Cerebrospinal Fluid of Patients with Alzheimer's Disease
- (2018) Barbara Mroczko et al. JOURNAL OF ALZHEIMERS DISEASE
- Evaluation of Matrix Metalloproteinase-2 (MMP-2) and -9 (MMP-9) and Their Tissue Inhibitors (TIMP-1 and TIMP-2) in Plasma from Patients with Neurodegenerative Dementia
- (2018) Gamze Tuna et al. JOURNAL OF ALZHEIMERS DISEASE
- Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?
- (2016) Subodh Kumar et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Matrix metalloproteinases in the brain and blood–brain barrier: Versatile breakers and makers
- (2016) Ralf G Rempe et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Accelerated pericyte degeneration and blood–brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer’s disease
- (2015) Matthew R Halliday et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Friends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative Diseases
- (2015) Marjana Brkic et al. MEDIATORS OF INFLAMMATION
- Apolipoprotein E controls cerebrovascular integrity via cyclophilin A
- (2012) Robert D. Bell et al. NATURE
- Matrix metalloproteinases in peripheral blood and cerebrospinal fluid in patients with Alzheimer's disease
- (2010) Solveig Horstmann et al. INTERNATIONAL PSYCHOGERIATRICS
- Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer's disease
- (2010) Erik Stomrud et al. Alzheimers Research & Therapy
- Matrix Metalloprotease-9 Inhibition Improves Amyloid -Mediated Cognitive Impairment and Neurotoxicity in Mice
- (2009) H. Mizoguchi et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now